Adult Onset Still's Disease

  • Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still's disease in Chinese individuals
    Zhiqiang Li, Hong-Lei Liu, Jianhua Chen, Ting Zeng, Lin He, Meihang Li, Cainan Luo, Shuang Liu, Ting-Ting Ding, Kuerbanjiang Yimaiti, Jialin Teng, Xingwang Li, Yonghe Ding, Xiaobing Cheng, Juan Zhou, Junna Ye, Jue Ji, Yu-Tong Su, Hui Shi, Yue Sun, Chengwen Gao, Qiongyi Hu, Huihui Chi, Xuan Yuan, Zhuochao Zhou, Dong Wang, Ke Wang, Chang-Gui Li, Yuanchao Sun, Yujuan Niu, Lin-Jie Chen, Jian Xu, Lijun Wu, Zhaowei Zhou, Dun Pan, Haitao Niu, Yongyong Shi, Chengde Yang
  • Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease
    Uta Kiltz, David Kiefer, Jürgen Braun, Eduardo Jorge Schiffrin, Charlotte Girard-Guyonvarc'h, Cem Gabay
  • Emergent high fatality lung disease in systemic juvenile arthritis
    Vivian E Saper, Guangbo Chen, Gail H Deutsch, R Paul Guillerman, Johannes Birgmeier, Karthik Jagadeesh, Scott Canna, Grant Schulert, Robin Deterding, Jianpeng Xu, Ann N Leung, Layla Bouzoubaa, Khalid Abulaban, Kevin Baszis, Edward M Behrens, James Birmingham, Alicia Casey, Michal Cidon, Randy Q Cron, Aliva De, Fabrizio De Benedetti, Ian Ferguson, Martha P Fishman, Steven I Goodman, T Brent Graham, Alexei A Grom, Kathleen Haines, Melissa Hazen, Lauren A Henderson, Assunta Ho, Maria Ibarra, Christi J Inman, Rita Jerath, Khulood Khawaja, Daniel J Kingsbury, Marisa Klein-Gitelman, Khanh Lai, Sivia Lapidus, Clara Lin, Jenny Lin, Deborah R Liptzin, Diana Milojevic, Joy Mombourquette, Karen Onel, Seza Ozen, Maria Perez, Kathryn Phillippi, Sampath Prahalad, Suhas Radhakrishna, Adam Reinhardt, Mona Riskalla, Natalie Rosenwasser, Johannes Roth, Rayfel Schneider, Dieneke Schonenberg-Meinema, Susan Shenoi, Judith A Smith, Hafize Emine Sönmez, Matthew L Stoll, Christopher Towe, Sara O Vargas, Richard K Vehe, Lisa R Young, Jacqueline Yang, Tushar Desai, Raymond Balise, Ying Lu, Lu Tian, Gill Bejerano, Mark M Davis, Purvesh Khatri, Elizabeth D Mellins
  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
    Angelo Ravelli, Francesca Minoia, Sergio Davì, AnnaCarin Horne, Francesca Bovis, Angela Pistorio, Maurizio Aricò, Tadej Avcin, Edward M Behrens, Fabrizio De Benedetti, Lisa Filipovic, Alexei A Grom, Jan-Inge Henter, Norman T Ilowite, Michael B Jordan, Raju Khubchandani, Toshiyuki Kitoh, Kai Lehmberg, Daniel J Lovell, Paivi Miettunen, Kim E Nichols, Seza Ozen, Jana Pachlopnik Schmid, Athimalaipet V Ramanan, Ricardo Russo, Rayfel Schneider, Gary Sterba, Yosef Uziel, Carol Wallace, Carine Wouters, Nico Wulffraat, Erkan Demirkaya, Hermine I Brunner, Alberto Martini, Nicolino Ruperto, Randy Q Cron
  • Evidence in support of the validity of the TNF brake hypothesis
    Walter P Maksymowych
  • Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
    Michael J Ombrello, Victoria L Arthur, Elaine F Remmers, Anne Hinks, Ioanna Tachmazidou, Alexei A Grom, Dirk Foell, Alberto Martini, Marco Gattorno, Seza Özen, Sampath Prahalad, Andrew S Zeft, John F Bohnsack, Norman T Ilowite, Elizabeth D Mellins, Ricardo Russo, Claudio Len, Maria Odete E Hilario, Sheila Oliveira, Rae S M Yeung, Alan M Rosenberg, Lucy R Wedderburn, Jordi Anton, Johannes-Peter Haas, Angela Rosen-Wolff, Kirsten Minden, Klaus Tenbrock, Erkan Demirkaya, Joanna Cobb, Elizabeth Baskin, Sara Signa, Emily Shuldiner, Richard H Duerr, Jean-Paul Achkar, M Ilyas Kamboh, Kenneth M Kaufman, Leah C Kottyan, Dalila Pinto, Stephen W Scherer, Marta E Alarcón-Riquelme, Elisa Docampo, Xavier Estivill, Ahmet Gül, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Carl D Langefeld, Susan Thompson, Eleftheria Zeggini, Daniel L Kastner, Patricia Woo, Wendy Thomson
  • Cadmium the missing link between smoking and increased rheumatoid disease activity?
    Matthew Cates, David Hutchinson
  • Risk of vascular disease with gout: overadjustment of the statistical analyses?
    Caroline M van Durme, Bart Spaetgens, Annelies Boonen, Frank de Vries
  • Response to: ‘Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry’ by Favalli et al
    Roy Fleischmann, Eustratios Bananis
  • Response to: ‘Detection of antinuclear antibodies: added-value of solid phase assay?’ by Bossuyt and Fieuws
    Nancy Agmon-Levin, Jan Damoiseaux, Yehuda Shoenfeld

Pages